Contraindicated Combination • Long Interaction Context

Tadalafil and Nitrates: Interaction, Blood Pressure & Contraindication

Tadalafil and organic nitrates should not be used together under current U.S. labeling. The contraindication applies to regular or intermittent nitrate use because tadalafil can potentiate the hypotensive effect of nitrates and cause blood pressure to fall to an unsafe level.

The interaction reflects overlapping nitric oxide and cyclic GMP signaling. Organic nitrates increase vasodilatory signaling through the NO-cGMP pathway, while tadalafil inhibits PDE5, the enzyme responsible for breaking down cGMP; combining those effects can amplify systemic vasodilation.

Tadalafil's long persistence makes timing clinically important, but the label does not convert the interaction into a consumer-directed waiting-period rule. A dedicated nitroglycerin study evaluated the interaction through 96 hours, and the label's 48-hour language applies only to a life-threatening situation in which nitrate administration is medically necessary under close medical supervision.

Tadalafil and Nitrates at a Glance

The nitrate interaction is one of tadalafil's formal contraindicated drug combinations. It is not classified merely as an interaction to monitor or a precaution to manage with routine dose spacing.

Current labeling applies the contraindication broadly to any form of organic nitrate, whether used regularly or intermittently. The underlying concern is excessive blood-pressure lowering from overlapping vasodilatory signaling.

This page focuses specifically on the nitrate mechanism and timing evidence; the complete list of formal exclusions remains on the tadalafil contraindications page.

Question Current label answer
Tadalafil + organic nitrate Contraindicated
Regular nitrate use Contraindicated
Intermittent nitrate use Contraindicated
Primary concern Potentiation of nitrate-induced hypotension
Routine management by self-directed dose spacing Not supported as a substitute for the contraindication

Why Tadalafil and Nitrates Can Produce Excessive Blood-Pressure Lowering

Nitric oxide stimulates formation of cyclic guanosine monophosphate, or cGMP, in smooth muscle. Increased cGMP promotes smooth-muscle relaxation and vasodilation.

Tadalafil inhibits phosphodiesterase type 5, or PDE5, which increases the amount of cGMP available in tissues where PDE5 is active. Organic nitrates add nitric oxide-driven signaling to the same broader pathway, so the combination can produce a substantially stronger vasodilatory effect than either exposure would suggest in isolation.

The clinically important consequence is hypotension rather than simply an increase in tadalafil concentration. This makes the nitrate interaction primarily pharmacodynamic, unlike CYP3A4 interactions that change tadalafil exposure.

Step Effect
Organic nitrate Increases nitric oxide-related signaling
Nitric oxide Promotes cGMP formation
cGMP Relaxes vascular smooth muscle
Tadalafil Inhibits PDE5-mediated cGMP breakdown
Combined effect Potentially excessive vasodilation and blood-pressure reduction

This Is a Pharmacodynamic Interaction, Not Primarily a Metabolic One

The nitrate contraindication is not based on nitrates raising tadalafil blood levels or tadalafil blocking nitrate metabolism. The major concern is that both exposures amplify a shared vasodilatory signaling system.

That distinction explains why this interaction is treated differently from a CYP3A4 inhibitor, which can increase tadalafil AUC or Cmax by slowing metabolism. A pharmacodynamic combination can be dangerous even when neither drug meaningfully changes the other's plasma concentration.

The broader interaction taxonomy is summarized on the tadalafil drug-interactions hub.

Interaction type Tadalafil + nitrates
Primary category Pharmacodynamic
Main variable affected Vasodilatory / blood-pressure effect
Requires increased tadalafil concentration? No
Regulatory outcome Contraindicated

What Counts as an Organic Nitrate?

Current CIALIS patient information gives concrete examples because patients may not recognize a medicine as a nitrate from its brand name or dosage form. It specifically names nitroglycerin, isosorbide dinitrate and isosorbide mononitrate.

Nitroglycerin can be supplied in several forms, including tablets, sprays, ointments, pastes and patches. The contraindication is therefore not limited to one route of administration or to a tablet taken every day.

If the identity of a medicine is uncertain, current patient information advises checking with a healthcare professional or pharmacist rather than assuming it is compatible with tadalafil.

Example Current CIALIS patient-information context
Nitroglycerin Organic nitrate; multiple dosage forms are mentioned
Isosorbide dinitrate Organic nitrate
Isosorbide mononitrate Organic nitrate

Nitroglycerin Form Does Not Remove the Contraindication

CIALIS patient information specifically notes nitroglycerin in tablets, sprays, ointments, pastes and patches. That breadth matters because a person may incorrectly assume the interaction applies only to sublingual tablets used for an acute angina episode.

The prescribing information instead contraindicates any form of organic nitrate used regularly or intermittently. Route or frequency does not turn routine combined use into an acceptable interaction.

The exact medication list should therefore be reviewed by active ingredient rather than by dosage form alone.

Nitroglycerin form mentioned in patient information Excluded from the nitrate warning?
Tablet No
Spray No
Ointment / paste No
Patch No

Recreational 'Poppers' Are Also Relevant to the Nitrate Warning

Current CIALIS patient information warns that some recreational products known as 'poppers' contain nitrates or nitrites, including amyl nitrite and butyl nitrite. They are specifically included in the patient-facing do-not-use guidance.

This is clinically important because a recreational substance may not be perceived as a medication and therefore may be omitted from a medication history. The interaction concern remains excessive vasodilation and unsafe blood-pressure lowering.

The presence of a recreational product rather than a prescription bottle does not make the nitrate-related warning irrelevant.

Substance example Patient-label context
Amyl nitrite Mentioned in connection with recreational 'poppers'
Butyl nitrite Mentioned in connection with recreational 'poppers'
Reason for inclusion Potential nitrate/nitrite-related interaction with tadalafil

How the Tadalafil–Nitroglycerin Interaction Was Studied

Current CIALIS clinical pharmacology includes a dedicated study designed to determine when the blood-pressure interaction with nitroglycerin was no longer apparent after tadalafil exposure. It was a double-blind, placebo-controlled, crossover study involving 150 men aged at least 40 years, including some participants with diabetes or controlled hypertension.

Participants received tadalafil 20 mg once daily or matching placebo for 7 days. After the final tadalafil or placebo dose, a single 0.4 mg dose of sublingual nitroglycerin was administered at prespecified timepoints.

The study design is important because its timing results come from a specific controlled regimen rather than from a theoretical calculation based only on tadalafil's half-life.

Study feature Design
Design Double-blind, placebo-controlled, crossover
Participants 150 men aged ≥40 years
Tadalafil regimen 20 mg daily for 7 days
Comparator Matching placebo
Nitroglycerin challenge 0.4 mg sublingual NTG
Post-tadalafil timepoints 2, 4, 8, 24, 48, 72 and 96 hours

What the Nitroglycerin Timing Study Found

A significant interaction between tadalafil and nitroglycerin was observed at each tested timepoint through and including 24 hours after the last tadalafil dose. This provides direct clinical pharmacology evidence that the interaction can persist well beyond the immediate dosing period.

At 48 hours, the interaction was no longer observed by most hemodynamic measures, although a few more tadalafil-treated participants than placebo-treated participants still experienced greater blood-pressure lowering. After 48 hours, the interaction was not detectable in the study.

These findings support the label's conservative emergency-management language, but they should not be converted into a routine consumer rule for scheduling nitrates around tadalafil.

Time after last tadalafil dose in the study Nitroglycerin interaction result
2 hours Significant interaction observed
4 hours Significant interaction observed
8 hours Significant interaction observed
24 hours Significant interaction observed
48 hours Not observed by most hemodynamic measures, but greater BP lowering still occurred in a few more tadalafil subjects than placebo
72 hours Interaction not detectable
96 hours Interaction not detectable

What the 48-Hour Nitrate Language Actually Means

Current CIALIS labeling contains a narrow provision for a patient who has already taken tadalafil and then develops a life-threatening situation in which nitrate administration is considered medically necessary. In that circumstance, the label states that at least 48 hours should elapse after the last tadalafil dose before nitrate administration is considered.

The same labeling immediately adds that nitrates should still be administered only under close medical supervision with appropriate hemodynamic monitoring. The 48-hour statement therefore describes emergency clinician-directed management; it does not cancel the routine contraindication.

It should not be interpreted as permission for a patient to plan nitrate use independently after counting 48 hours.

Interpretation of 48 hours Correct?
Routine tadalafil and nitrate use becomes acceptable after a self-selected 48-hour interval No
The wording applies to a life-threatening situation where nitrate therapy is medically necessary Yes
At least 48 hours should have elapsed before nitrate administration is considered in that circumstance Yes
Medical supervision and hemodynamic monitoring are still required Yes
The underlying nitrate contraindication disappears No

Why Tadalafil's Long Half-Life Matters

Tadalafil has a mean terminal half-life of approximately 17.5 hours in healthy subjects. Its concentration therefore declines gradually rather than disappearing shortly after a dose, helping explain why interaction considerations extend well beyond the first few hours.

The half-life provides pharmacokinetic context, but the nitrate guidance should not be reconstructed by simply multiplying 17.5 hours by a chosen number of half-lives. The 48-hour emergency language is supported by direct nitroglycerin interaction data and regulatory interpretation, not by a simple mathematical half-life rule.

The PK meaning of 17.5 hours is covered separately on the tadalafil half-life page.

Concept Meaning
Mean terminal tadalafil half-life Approximately 17.5 hours in healthy subjects
Does tadalafil disappear after one half-life? No
Can the nitrate rule be derived from half-life alone? No
Best basis for the label timing context Direct clinical pharmacology interaction study plus current labeling

Tadalafil Can Remain in the Body for More Than Two Days

Current CIALIS patient information states that after a single tablet, some active ingredient remains in the body for more than 2 days. It also notes that tadalafil may remain longer in people with kidney or liver problems or when certain other medications are used.

This patient-facing statement reinforces why a short interval after tadalafil should not be assumed to eliminate interaction potential. It also shows why a generic one-size-fits-all timing calculation based only on the clock can be misleading.

Organ-function effects on tadalafil exposure are addressed in more detail on the renal impairment and hepatic impairment pages.

Factor Potential relevance
Single tadalafil tablet Some active ingredient remains for more than 2 days
Kidney impairment Can prolong or increase tadalafil exposure
Liver impairment Can change tadalafil handling and labeled use
Certain interacting medicines Can increase tadalafil exposure

Once-Daily Tadalafil Does Not Create a Nitrate Exception

Once-daily tadalafil produces continuous plasma exposure. Current labeling specifically calls attention to ongoing interaction potential when tadalafil is prescribed every day.

The nitrate contraindication remains in place for daily treatment just as it does for as-needed treatment. A lower daily tablet strength should not be interpreted as eliminating the pharmacodynamic interaction.

The exposure pattern of repeated dosing is covered on the daily tadalafil page.

Tadalafil regimen Organic nitrate status
As-needed use Contraindicated with organic nitrates
Once-daily use Contraindicated with organic nitrates
Lower tadalafil strength Does not remove the formal nitrate contraindication

What Can Excessive Blood-Pressure Lowering Cause?

Current CIALIS patient counseling warns that taking tadalafil with nitrates can cause blood pressure to fall suddenly to an unsafe level. The label specifically mentions dizziness, syncope and potentially serious cardiovascular consequences.

This is different from tadalafil's modest average blood-pressure effect when studied alone in healthy subjects. The interaction matters because nitrate-mediated vasodilation can be amplified by PDE5 inhibition.

For tadalafil's broader blood-pressure pharmacology outside the nitrate contraindication, see the tadalafil blood-pressure guide.

Potential consequence mentioned in patient counseling Clinical context
Dizziness Possible consequence of unsafe blood-pressure lowering
Syncope / fainting Possible consequence of marked hypotension
Serious cardiovascular event Patient counseling warns of potentially severe consequences when BP falls to an unsafe level

Chest Pain After Tadalafil Requires Medical Rather Than Self-Directed Nitrate Management

CIALIS patient counseling specifically addresses the possibility of anginal chest pain after tadalafil use. Patients who experience anginal chest pain after taking CIALIS are instructed to seek immediate medical attention rather than independently using a nitrate according to a self-calculated interval.

The label also emphasizes that emergency healthcare professionals should know when tadalafil was last taken. That timing information matters because clinicians may need to evaluate both the nitrate contraindication and alternative management options.

This page does not provide individualized emergency-medication instructions beyond the current label because nitrate decisions in this setting require medical supervision.

Situation Label-supported response
Anginal chest pain after tadalafil Seek immediate medical attention
Emergency healthcare encounter Healthcare professionals should be told when tadalafil was last taken
Self-directed nitrate use Not supported by the CIALIS counseling framework

Nitrates Are Not Managed Like Ordinary Antihypertensive Drugs

Tadalafil can interact with several medicines that lower blood pressure, but their regulatory categories differ. Alpha-blockers and antihypertensives generally appear under caution or additive blood-pressure-effect guidance, whereas organic nitrates are formally contraindicated.

The difference is important because a user should not infer that a tolerated combination with one blood-pressure medicine means nitrates are also acceptable. Interaction management is specific to the drug class and mechanism.

The complete hierarchy is summarized on the drug-interactions page.

Drug class Tadalafil interaction category
Organic nitrates Contraindicated
Alpha-blockers Caution / indication-specific not-recommended framework
Other antihypertensives Potential additive blood-pressure lowering
GC stimulators such as riociguat Separate formal contraindication

Nitrates and Riociguat Share a Contraindication Outcome but Not the Same Mechanism

Organic nitrates and guanylate cyclase stimulators such as riociguat are both contraindicated with tadalafil because of excessive hypotensive potential, but they are different pharmacologic classes. Nitrates act through nitric oxide-related signaling, while riociguat directly stimulates soluble guanylate cyclase and also sensitizes it to nitric oxide.

The two categories should therefore remain separate within the safety architecture. A nitrate-specific page should not become a duplicate of the riociguat interaction page merely because both ultimately affect cGMP and blood pressure.

The GC-stimulator mechanism is covered on the tadalafil and riociguat page.

Interaction Drug class Tadalafil status
Organic nitrates NO-donor / nitrate therapy Contraindicated
Riociguat Guanylate cyclase stimulator Contraindicated

Common Misunderstandings About Tadalafil and Nitrates

Several common interpretations weaken or distort the actual label. The nitrate contraindication does not apply only to high tadalafil doses, daily nitrate users or one particular nitroglycerin formulation.

Likewise, the 48-hour emergency language is not a general permission rule, and tadalafil's 17.5-hour half-life should not be used to create a personal nitrate schedule. The clinical pharmacology study and current labeling provide the relevant evidence framework.

Keeping these distinctions explicit is especially important because nitrates may be used intermittently, meaning a person may not think of them as part of a routine medication list.

Misunderstanding Correct interpretation
Only daily nitrates are contraindicated Regular and intermittent organic nitrate use are both contraindicated
Only nitroglycerin tablets matter The contraindication covers any form of organic nitrate
A low tadalafil dose removes the interaction No
48 hours is a routine self-directed scheduling rule No; the label uses it in a life-threatening clinician-directed context
The 48-hour framework comes only from multiplying tadalafil's half-life No; direct nitroglycerin interaction data support the timing context

Tadalafil–Nitrate Interaction Checklist

A safe interaction review starts by identifying nitrate exposure before focusing on dose timing. Prescription nitrates, intermittent angina treatment and relevant recreational substances can all be missed if the review is limited to medicines taken every day.

The key distinction is whether an organic nitrate is involved at all; routine tadalafil use with that nitrate is contraindicated under current U.S. labeling.

Check Question
Medication identity Is nitroglycerin, isosorbide dinitrate, isosorbide mononitrate or another organic nitrate being used?
Frequency Is nitrate use intermittent as well as regular?
Dosage form Could the nitrate be a spray, patch, ointment, paste or tablet?
Recreational exposure Are nitrate/nitrite-containing 'poppers' relevant?
Tadalafil regimen Is tadalafil used as needed or daily? The nitrate contraindication applies to both frameworks
Emergency context If urgent cardiac care is needed, do healthcare professionals know when tadalafil was last taken?

Key Takeaways About Tadalafil and Nitrates

Tadalafil is contraindicated with any form of organic nitrate, whether nitrate use is regular or intermittent. The interaction is pharmacodynamic: overlapping NO-cGMP signaling can produce excessive vasodilation and potentially unsafe blood-pressure lowering.

Controlled clinical pharmacology data provide direct timing evidence. In the label-described nitroglycerin study, a significant interaction was observed through 24 hours; at 48 hours it was absent by most hemodynamic measures although some greater blood-pressure lowering remained in a few more tadalafil-treated participants, and after 48 hours the interaction was not detectable.

The label's at-least-48-hour language applies only when nitrate therapy is considered medically necessary in a life-threatening situation and still requires close medical supervision and hemodynamic monitoring. It does not replace the routine contraindication or provide a self-directed nitrate schedule.

Frequently Asked Questions

No routine concomitant use is permitted under current U.S. CIALIS labeling. Tadalafil is contraindicated in patients using any form of organic nitrate, whether nitrate use is regular or intermittent.

Tadalafil inhibits PDE5 and increases cGMP signaling, while organic nitrates increase nitric oxide-driven cGMP formation. Combining the effects can produce excessive vasodilation and potentially unsafe blood-pressure lowering.

Routine combined use is contraindicated. Nitroglycerin is an organic nitrate, and current CIALIS labeling states that tadalafil potentiates the hypotensive effect of nitrates.

Yes. Current labeling explicitly applies the contraindication to organic nitrate use whether it is regular or intermittent.

Current CIALIS patient information specifically mentions nitroglycerin, isosorbide dinitrate and isosorbide mononitrate. Other organic nitrates also fall under the formal contraindication.

Yes. CIALIS patient information specifically notes nitroglycerin in forms including tablets, sprays, ointments, pastes and patches. The contraindication is not limited to one nitroglycerin formulation.

Current CIALIS patient information warns against recreational 'poppers' containing nitrates or nitrites such as amyl nitrite or butyl nitrite because they can create the same dangerous vasodilatory interaction context.

In the clinical pharmacology study described in current CIALIS labeling, a significant tadalafil–nitroglycerin interaction was observed at every tested timepoint through 24 hours. At 48 hours it was no longer seen by most hemodynamic measures, although greater blood-pressure lowering still occurred in a few more tadalafil-treated subjects; after 48 hours the interaction was not detectable.

The 48-hour language applies to a life-threatening situation in which nitrate administration is considered medically necessary after tadalafil. Current labeling states that at least 48 hours should have elapsed before nitrate administration is considered, and nitrates should still be given only under close medical supervision with appropriate hemodynamic monitoring.

No. The current CIALIS label continues to classify routine concomitant nitrate use as contraindicated. The 48-hour statement is narrow emergency medical guidance, not a general self-directed permission rule.

Tadalafil declines gradually because its mean terminal half-life is about 17.5 hours in healthy subjects, so meaningful drug exposure can persist well beyond the first several hours. However, nitrate timing guidance should be based on current labeling and direct interaction evidence rather than calculated from half-life alone.

No. Current labeling bases the interaction context on a controlled nitroglycerin study as well as tadalafil pharmacology. The 48-hour emergency language should not be reconstructed from a simple half-life calculation.

The label describes a double-blind, placebo-controlled crossover study in 150 men aged at least 40 years. Participants received tadalafil 20 mg daily or placebo for 7 days, followed by 0.4 mg sublingual nitroglycerin at prespecified times after the final dose.

The current CIALIS label reports nitroglycerin testing at 2, 4, 8, 24, 48, 72 and 96 hours after the last dose of tadalafil in the dedicated interaction study.

Yes. A significant interaction was observed at each tested timepoint through and including 24 hours in the current label-described study.

At 48 hours, the interaction was not observed by most hemodynamic measures, although a few more tadalafil-treated subjects than placebo-treated subjects experienced greater blood-pressure lowering. The label still uses an at-least-48-hour threshold only within its medically necessary life-threatening emergency framework.

No. Once-daily tadalafil creates continuous plasma exposure, but organic nitrate use remains contraindicated. A lower daily tadalafil strength does not create a nitrate exception.

Yes. The formal nitrate contraindication applies to tadalafil use generally; it is not limited to 10 mg or 20 mg tablets.

Current CIALIS counseling instructs patients who experience anginal chest pain after taking the drug to seek immediate medical attention. Emergency healthcare professionals should be told when tadalafil was last taken so they can manage the interaction context appropriately.

No. Both are contraindicated with tadalafil because of hypotensive potential, but they are different drug classes. Organic nitrates act through nitric oxide-related signaling, while riociguat is a guanylate cyclase stimulator with its own interaction mechanism.